{
    "N/R/U": null,
    "Applicant": "Amgen Inc.",
    "BLA Number": "761285",
    "Proprietary Name": "Wezlana",
    "Proper Name": "ustekinumab-auub",
    "BLA Type": "351(k) Interchangeable",
    "Strength": "45MG/0.5ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Pre-Filled Syringe",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "October 31, 2023",
    "Ref. Product Proper Name": "ustekinumab",
    "Ref. Product Proprietary Name": "Stelara",
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "1080",
    "Product Number": "001",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": "April 30, 2025",
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "ustekinumab-auub",
            "drugbank_id": "https://go.drugbank.com/drugs/DB05679"
        }
    ]
}